MILLENNIUM MANAGEMENT LLC

Position in MYGN — Myriad Genetics Inc

CIK 1273087 NEW YORK, NY

Back to MYGN Full portfolio

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,009,676

-$11,196,295 QoQ

Shares Held

6,668,817

-0.5% QoQ

Ownership

7.06%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Derivatives in MYGN

reported options exposure · as of Mar 31, 2025

CallValue

$709,600

CallShares

80,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $788,320,547 across 32 Diagnostics & Research names. MYGN ranks #11 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRL	Charles River Laboratories International, Inc.	934,045	$161,122,762
2	GH	Guardant Health, Inc.	921,395	$85,109,256
3	A	Agilent Technologies, Inc.	686,546	$78,252,513
4	WAT	Waters Corp /De/	185,168	$55,143,030
5	IQV	Iqvia Holdings Inc.	268,185	$45,736,269
6	IDXX	Idexx Laboratories Inc /De	70,446	$39,582,902
7	TMO	Thermo Fisher Scientific Inc.	70,696	$34,749,204
8	DHR	Danaher Corp /De/	182,825	$34,663,620

All Filings in MYGN

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,009,676	6,668,817	-0.5%	Shares	Sole	2026-05-15
2025-12-31	$41,205,971	6,700,158	+41.1%	Shares	Sole	2026-02-17
2025-09-30	$34,330,404	4,748,327	-3.6%	Shares	Sole	2025-11-14
2025-06-30	$26,150,231	4,924,714	+6055.9%	Shares	Sole	2025-08-14
2025-03-31	$709,600	80,000	-98.0%	Call	Sole	2025-05-15
2025-03-31	$36,096,695	4,069,526	+1407.2%	Shares	Sole	2025-05-15
2024-12-31	$3,701,700	270,000	-93.8%	Call	Sole	2025-02-14
2024-12-31	$59,572,637	4,345,196	-16.1%	Shares	Sole	2025-02-14
2024-09-30	$141,784,636	5,176,511	+6765.4%	Shares	Sole	2024-11-14
2024-06-30	$1,844,284	75,400	-98.3%	Put	Sole	2024-08-14
2024-06-30	$107,599,833	4,399,012	+14563.4%	Shares	Sole	2024-08-14
2024-06-30	$733,800	30,000	-86.4%	Call	Sole	2024-08-14
2024-03-31	$4,690,400	220,000	-94.6%	Call	Sole	2024-05-15
2024-03-31	$86,858,490	4,074,038	+17.7%	Shares	Sole	2024-05-15
2023-12-31	$66,249,990	3,461,337	+3361.3%	Shares	Sole	2024-02-14
2023-12-31	$1,914,000	100,000	+233.3%	Call	Sole	2024-02-14
2023-12-31	$574,200	30,000	-99.1%	Put	Sole	2024-02-14
2023-09-30	$55,838,496	3,481,203	+1327.3%	Shares	Sole	2023-11-14
2023-09-30	$3,912,156	243,900	-73.2%	Call	Sole	2023-11-14
2023-06-30	$21,057,824	908,448	+4353.2%	Shares	Sole	2023-08-14
2023-03-31	$473,892	20,400	-98.5%	Call	Sole	2023-05-15
2023-03-31	$32,182,632	1,385,391	-5.9%	Shares	Sole	2023-05-15
2022-12-31	$21,364,756	1,472,416	+7153.3%	Shares	Sole	2023-02-14
2022-09-30	$387,324	20,300	-98.4%	Call	Sole	2022-11-14
2022-09-30	$24,159,763	1,266,235	+793.0%	Shares	Sole	2022-11-14
2022-06-30	$2,576,506	141,800	-58.9%	Call	Sole	2022-08-15
2022-03-31	$8,693,672	344,987	+130.0%	Shares	Sole	2022-05-16
2022-03-31	$3,780,000	150,000	-38.8%	Call	Sole	2022-05-16
2021-12-31	$6,762,000	245,000	-80.1%	Call	Sole	2022-02-14
2021-12-31	$33,996,162	1,231,745	+86.7%	Shares	Sole	2022-02-14
2021-09-30	$21,298,193	659,591	-26.2%	Shares	Sole	2021-11-15
2021-06-30	$27,323,841	893,520	+8835.2%	Shares	Sole	2021-08-16
2021-06-30	$305,800	10,000	-98.9%	Put	Sole	2021-08-16
2021-03-31	$26,950,168	885,063	+4325.3%	Shares	Sole	2021-05-17
2021-03-31	$609,000	20,000	-98.4%	Put	Sole	2021-05-17
2020-12-31	$24,529,587	1,240,748	+11.3%	Shares	Sole	2021-02-16
2020-09-30	$14,533,927	1,114,565	+2500.0%	Shares	Sole	2020-11-16
2020-06-30	$486,123	42,868	-24.5%	Shares	Sole	2020-08-14
2020-03-31	$812,979	56,812	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.